The pharmaceuticals grade sodium bicarbonate industry is set to experience robust growth, with a projected Compound Annual Growth Rate (CAGR) of 3.5% from 2023 to 2033. In 2023, the market is expected to be worth US$ 265.3 million and is poised to reach an impressive valuation of US$ 372.4 million by the end of the forecast period. Research conducted by Future Market Insights reveals that the global market generated US$ 256.0 million in revenue in 2022, underlining its steady growth trajectory in the pharmaceutical sector.
The global pharmaceutical-grade sodium bicarbonate market is reliant on the pharmaceutical industry as a pH buffering agent. For electrolyte replenishing, as a systemic alkalizer, and in topical cleansing solutions, it has been used excessively. Furthermore, the demand from hospitals, the personal care industry, and healthcare institutions is expected to benefit the global market.
Considerable growth in the pharmaceutical industry along with accelerated sales of chemicals is predicted to boost the demand across the evaluation period. Moreover, the pharmaceutical industry is one of the key consumers of sodium bicarbonate. Over recent years, various pharma companies have been forced to shift their operating methods by adopting the latest technology. This new and sudden spur in the adoption of new technologies and innovation to support virtual work led to a significant rise in the overall market.
Request a Sample Report and Explore New Growth Opportunities Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-6459
Compelling Market Trends
Active pharmaceutical ingredients are known as chemical compounds in medicines that have a significant effect on the body. Such drugs containing soda-bicarbonate help activate an anti-inflammatory pathway and prevent autoimmune diseases. Some medicines called OTC (over-the-counter) medicines contain pharma-grade baking soda as an active pharma ingredient.
Over-the-counter drugs are the types of medicines that can be bought without any specific prescription according to the guidelines issued by the FDA (Food and Drug Administration). The FDA considers the consumption of these medicines as safe without any medical supervision. Furthermore, these drugs are utilized to treat various genetic health problems such as sleeping-related problems, cough and cold, pain, smoking cessation, itches, weight problems, tooth decay, gastrointestinal problems, and various others.
Awareness and media advertising made people aware of self-medication for occasional heartburn and acidity and the availability of antacids in over-the-counter (OTC) sales has emerged as one of the prime factors for antacids and similar products’ growth. In addition, antacids are known as one of the most popular over-the-counter medicines. Consistent growth in sales of antacids, baking soda, or sodium bicarbonate is the key ingredient for any kind of antacids. Steady growth in sales of antacids is promoting the demand with consistent growth rates.
Growth Drivers
The growth of the market is attributed to the advancements in research and developments, the transformation of digital platforms and IT is currently the top strategic priority for pharmaceutical companies and is expected to continue to be so in the future.
Pharmaceutical Grade Sodium Bicarbonate is expected to register significant growth during the assessment period. Based on geography East Asia is estimated to dominate the market owing to the presence of leading manufacturing units of leading pharmaceutical companies in China. The prominent over-the-counter categories comprise cough-cold and allergy, vitamins, weight loss and nutrition, pain relief, and digestives which collectively accounted for a significant share of all over-the-counter sales in 2022.
Over the past five years, several developments have taken place in the market. Numerous leading companies devised their plans to fend off possible threats and seize the medium- and long-term possibilities presented by this shifting environment and focused on the development of soda bicarbonate drugs with a fine grade for the treatment of a wide range of diseases.
Gain Immediate Access to Detailed Market Insights: https://www.futuremarketinsights.com/checkout/6459
Competitive Landscape
Leading manufacturers operating in the global pharmaceuticals grade sodium bicarbonate market are focusing on developing high-quality pharma-grade-baking soda and developing technologies for mining. Key players in the market are focusing on generating revenue by exploring potential applications. Players are expanding their geographical boundaries to expand their consumer base.
Key Companies Profiled
- Tata Chemicals
- Novacarb (Novacap Group)
- Dr. Paul Lohmann GmbH KG
- GHCL Limited
- CIECH S.A.
- Natural Soda LLC
- Jost Chemical Co.
- Tornox Alkali Corporation
Recent Developments
On September 11, 2019, Exela Pharma Sciences is to announce the launch of Sodium Bicarbonate Injection, USP. Exela received approval for its ANDA for Sodium Bicarbonate Injection in May for four separate presentations. This product has been on the FDA Drug Shortage list consistently and is only the second FDA Approved Sodium Bicarbonate Injection on the US market.
Valuable Insights into the Pharmaceuticals Grade Sodium Bicarbonate Market
China is anticipated to account for a dominant market share of around 23.8% over the forecast period. The growth of the market is generated by key players present in China which have significant opportunities to leverage revenue generation in the country.
Segmentation of Industry Research
By Grade:
- Fine
- Coarse
By Application:
- Active Pharmaceutical Ingredients
- Excipients
- Antacids
- Haemodialysis
- Tablet Coating
- Toothpaste
- Others
By Region:
- North America
- Latin America
- Eastern Europe
- Western Europe
- SEA and Pacific
- China
- India
- Japan
- Middle East and Africa
Upcoming Trending Reports:
As per Future Market Insights, the 2-acetylthiophene market is anticipated to attain a value pool of US$ 90 billion by 2023-end. Global demand for 2-acetylthiophene is expected to rise at a CAGR of 5.2% to US$ 150 billion in 2033.
As per Future Market Insights, the Ester Gums market is anticipated to attain a value pool of US$ 700 Million by 2023-end. Global demand for Ester Gums is expected to rise at a CAGR of 7.9% to US$ 1500 Million in 2033.
As per Future Market Insights, the Dibutyl Ether market is anticipated to attain a value pool of US$ 4 Billion by 2023-end. Global demand for Dibutyl Ether is expected to rise at a CAGR of 5.8% to US$ 7 Billion in 2033.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
